Evidence map›Paper›PMID 36525463›Full record

ArticlePLoS pathogens2022

Adaptation to HLA-associated immune pressure over the course of HIV infection and in circulating HIV-1 strains.

Eric Alves, Marwah Al-Kaabi, Niamh M Keane, Shay Leary, Coral-Ann M Almeida, Pooja Deshpande, Jennifer Currenti, Abha Chopra, Rita Smith, Alison Castley and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. HIV controllers: hope for a functional cure.Frontiers in immunology · 2025
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Eric AlvesSchool of Human Sciences, The University of Western Australia, Perth, Western Australia, Australia.ORCID 0000-0002-6072-708X
Marwah Al-KaabiSchool of Human Sciences, The University of Western Australia, Perth, Western Australia, Australia.
Niamh M KeaneInstitute for Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia.
Shay LearyInstitute for Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia.
Coral-Ann M AlmeidaInstitute for Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia.
Pooja DeshpandeSchool of Human Sciences, The University of Western Australia, Perth, Western Australia, Australia.
Jennifer CurrentiSchool of Human Sciences, The University of Western Australia, Perth, Western Australia, Australia.
Abha ChopraInstitute for Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia.
Rita SmithDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Alison CastleyDepartment of Clinical Immunology, Royal Perth Hospital, Perth, Western Australia, Australia.
Simon MallalInstitute for Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia.
Spyros A KalamsDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Silvana GaudieriSchool of Human Sciences, The University of Western Australia, Perth, Western Australia, Australia.ORCID 0000-0001-6873-0198
Mina JohnInstitute for Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia.
Murdoch University · AUThe University of Western Australia · AUVanderbilt University Medical Center · USRoyal Perth Hospital · AU

Funding

Tennessee CFAR: Implementation of Culturally Responsive Trauma-Informed Care with Youth with HIV in Memphis, TNP30AI110527 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Stephany Norah Duda · 2015 to 2026
$27.5M
6 · The paper itself

Abstract

Adaptation to human leukocyte antigen (HLA)-associated immune pressure represents a major driver of human immunodeficiency virus (HIV) evolution at both the individual and population level. To date, there has been limited exploration of the impact of the initial cellular immune response in driving viral adaptation, the dynamics of these changes during infection and their effect on circulating transmitting viruses at the population level. Capturing detailed virological and immunological data from acute and early HIV infection is challenging as this commonly precedes the diagnosis of HIV infection, potentially by many years. In addition, rapid initiation of antiretroviral treatment following a diagnosis is the standard of care, and central to global efforts towards HIV elimination. Yet, acute untreated infection is the critical period in which the diversity of proviral reservoirs is first established within individuals, and associated with greater risk of onward transmissions in a population. Characterizing the viral adaptations evident in the earliest phases of infection, coinciding with the initial cellular immune responses is therefore relevant to understanding which changes are of greatest impact to HIV evolution at the population level. In this study, we utilized three separate cohorts to examine the initial CD8+ T cell immune response to HIV (cross-sectional acute infection cohort), track HIV evolution in response to CD8+ T cell-mediated immunity over time (longitudinal chronic infection cohort) and translate the impact of HLA-driven HIV evolution to the population level (cross-sectional HIV sequence data spanning 30 years). Using next generation viral sequencing and enzyme-linked immunospot interferon-gamma recall responses to peptides representing HLA class I-specific HIV T cell targets, we observed that CD8+ T cell responses can select viral adaptations prior to full antibody seroconversion. Using the longitudinal cohort, we uncover that viral adaptations have the propensity to be retained over time in a non-selective immune environment, which reflects the increasing proportion of pre-adapted HIV strains within the Western Australian population over an approximate 30-year period.

Indexed as

HIV-1HIV InfectionsAustraliaCD8-Positive T-LymphocytesCross-Sectional StudiesHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA AntigensHumansHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA Antigens

Identifiers

PMID36525463
PMCPMC9803285
OpenAlexW4311651296

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.